NLS Pharmaceutics Ltd (NLSP)
3.36
+0.07
(+2.13%)
USD |
NASDAQ |
Nov 21, 14:28
NLS Pharmaceutics Price: 3.36 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 3.11 | 3.55 | 3.11 | 3.29 | 66385.00 |
| Nov 19, 2024 | 3.034 | 3.236 | 3.01 | 3.18 | 25816.00 |
| Nov 18, 2024 | 3.23 | 3.43 | 3.12 | 3.26 | 15735.00 |
| Nov 15, 2024 | 3.24 | 3.31 | 3.00 | 3.13 | 45863.00 |
| Nov 14, 2024 | 3.46 | 3.46 | 3.15 | 3.34 | 48519.00 |
| Nov 13, 2024 | 3.15 | 4.15 | 3.15 | 3.46 | 66192.00 |
| Nov 12, 2024 | 3.79 | 3.91 | 3.610 | 3.90 | 52073.00 |
| Nov 11, 2024 | 3.79 | 4.01 | 3.68 | 3.97 | 118814.0 |
| Nov 08, 2024 | 4.03 | 4.06 | 3.85 | 3.94 | 96820.00 |
| Nov 07, 2024 | 3.97 | 4.34 | 3.90 | 4.15 | 48294.00 |
| Nov 06, 2024 | 3.95 | 4.30 | 3.90 | 4.09 | 112079.0 |
| Nov 05, 2024 | 4.15 | 4.215 | 3.86 | 4.04 | 258917.0 |
| Nov 04, 2024 | 4.74 | 4.74 | 3.615 | 4.39 | 11.41M |
| Nov 01, 2024 | 3.81 | 3.81 | 3.56 | 3.60 | 10793.00 |
| Oct 31, 2024 | 3.65 | 3.90 | 3.63 | 3.63 | 7564.00 |
| Oct 30, 2024 | 4.20 | 4.385 | 3.510 | 3.86 | 28965.00 |
| Oct 29, 2024 | 4.09 | 4.23 | 3.90 | 4.13 | 19216.00 |
| Oct 28, 2024 | 4.18 | 4.200 | 3.80 | 4.11 | 60691.00 |
| Oct 25, 2024 | 4.30 | 4.46 | 4.18 | 4.18 | 8934.00 |
| Oct 24, 2024 | 4.497 | 4.65 | 4.22 | 4.26 | 14069.00 |
| Oct 23, 2024 | 4.70 | 4.95 | 4.30 | 4.605 | 27232.00 |
| Oct 22, 2024 | 5.00 | 5.177 | 4.75 | 4.84 | 10678.00 |
| Oct 21, 2024 | 5.20 | 5.40 | 4.52 | 4.760 | 51663.00 |
| Oct 18, 2024 | 5.00 | 5.643 | 4.85 | 5.30 | 28294.00 |
| Oct 17, 2024 | 5.00 | 5.25 | 4.889 | 5.18 | 17982.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.13
Minimum
Nov 15 2024
234.00
Maximum
Mar 12 2021
48.57
Average
35.96
Median
Jul 19 2023
Price Benchmarks
| AC Immune SA | 3.23 |
| CRISPR Therapeutics AG | 46.26 |
| Addex Therapeutics Ltd | 7.89 |
| Molecular Partners AG | 5.34 |
| MoonLake Immunotherapeutics | 51.63 |
Price Related Metrics
| Earnings Yield | -200.6% |
| Market Cap | 12.82M |